Arcoma AB

Stockholm Stock Exchange ARCOMA.ST

Arcoma AB Gross Profit Margin for the year ending December 31, 2023: 35.53%

Arcoma AB Gross Profit Margin is 35.53% for the year ending December 31, 2023, a -11.94% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Arcoma AB Gross Profit Margin for the year ending December 31, 2022 was 40.34%, a 13.46% change year over year.
Arcoma AB Gross Profit Margin for the year ending December 31, 2021 was 35.56%, a -7.74% change year over year.
Arcoma AB Gross Profit Margin for the year ending December 31, 2020 was 38.54%, a -0.74% change year over year.
Arcoma AB Gross Profit Margin for the year ending December 31, 2019 was 38.82%, a -0.84% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Stockholm Stock Exchange: ARCOMA.ST

Arcoma AB

CEO	Mr. Mattias Leire
IPO Date	Nov. 14, 2014
Location	Sweden
Headquarters	AnnavAegen 1
Employees	32
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.

Key trends

Past 5 years